Naoko Ubukata

T‐0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor‐deficient mice

Naoki Terasaka, Ayano Hiroshima, Tadashi Koieyama et al. · FEBS Letters · 2002 · 322 citations

Life Sciences, Molecular Biology, Pharmacology +17

Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist

Kiyoshi Arai, Tsuyoshi Homma, Yuka Morikawa et al. · European Journal of Pharmacology · 2015 · 133 citations

Medicine, Medicinal Chemistry, Pharmacology +7

CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats

Kiyoshi Arai, Yuka Morikawa, Naoko Ubukata et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 61 citations

Medicine, Pharmacology, Pharmacotherapy +14

ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice

Naoki Terasaka, Atsuhiro Miyazaki, Naomi Kasanuki et al. · Atherosclerosis · 2006 · 51 citations

Life Sciences, Biochemistry, Pharmacology +17

LXRα regulates human CETP expression in vitro and in transgenic mice

Shoko Honzumi, Akiko Shima, Ayano Hiroshima et al. · Atherosclerosis · 2010 · 36 citations

Life Sciences, Genetics, Molecular Biology +9